Glidewell Laboratories announced it is discontinuing its services for digital treatment planning and guided surgery for implant cases.
Glidewell introduced digital implant treatment planning to its customers in 2008, and it has experienced consistent revenue growth since that time. However, the complexity of current third-party digital treatment planning software programs and the prohibitive cost of surgical guides present significant obstacles to providing the reasonable fees that Glidewell's customers have come to expect, the company noted in a press release.
Glidewell is working with a few companies to provide clinicians with high-quality and cost-effective digital dental solutions. "In cooperation with these companies, we are creating unique software applications that make planning easier and more intuitive, and the overall process more efficient," said Grant Bullis, director of implant R&D at Glidewell.
Even though Glidewell is choosing to discontinue these services at this time, the laboratory continues to believe in the benefits of digital treatment planning, according to Greg Minzenmayer, chief operating officer.
